Abstract:1300 Introduction: Neuroinﬂammation is widely regarded as a chronic innate immune response in the brain and apotentially pathogenic factor in a number of neurodegenerative diseases such as Alzheimer’s disease (AD), as well as traumatic brain injury. Recently, due to its key signaling steps in the initiation of immune activation, greater attention has been paid to the potential of neuroinﬂammation as a therapeutic target. Microglia, which comprise approximately 20% of all glial cells, serve as the principal immune cells and play crucial roles in the central nervous system, responding to neuroinﬂammation via migration and the execution of phagocytosis. The activation of microglia is characterized by an increase in the expression level of TSPO, which can be detected by PET. Transmembrane protein 59 (Tmem59) is a membrane protein that plays an important role in neural stem cell differentiation, glioma apoptosis, dendritic spine formation, and Alzheimer’s disease (AD), nevertheless, the involvement of the Tmem59 gene in the brain immune response has not yet been reported. In the current work, we investigated the effect of Tmem59 in neuroinflammation. Methods: 18F-DPA-714 imaging in WT and KO mice were performed using a micro PET/CT. Tmem59 down-expression models and vector controls of BV2 microglia cells were established by psiRNA-Tmem59 and Vehicle plasmid transfection, respectively. The change of gene expression was detected by western blotting analysis. Cell phagocytosis assay was used to study the eﬀect of Dcf1 downregulation on the phagocytic ability of LPS-activated microglia Results: The activation of microglia is characterized by an increase in the expression level of TSPO and Iba1. Using this PET imaging technique, we found that TSPO expression was significantly increased in certain brain regions of Tmem59-KO mice, including the hippocampus, as compared with that of WT mice, indicating that Tmem59 deletion upregulated the ratio of activated microglia to resting microglia. Consistently, the expression level of Iba1 was also significantly increased in Tmem59-KO mice, as reflected by immunostaining and Western blotting analysis, which both show that the mean density in KO mice is 1.5 times that in WT mice. Furthermore, Western blotting analysis shows that the expression level of CD68 was significantly increased in Tmem59-KO mice. To explore the effect of Tmem59 downregulation on the phagocytic ability of LPS-activated microglia, a cell phagocytosis assay was performed. Image analysis shows that compared with the blank, the phagocytic capacity of BV2 cells following treatment with LPS was increased by approximately 10%. Moreover, downregulation of Tmem59 led to a significant decrease of approximately 50% in microglial phagocytic ability as compared with the LPS+vehicle group. Conclusion: In conclusion, our data indicates that Tmem59-deﬁcient microglia induced aberrant proinﬂammatory cytokines release and subsequent microglial dysfunction, which blocked the phagocytic abilities of activated microglia. Taken together, these observations provide novel insight into the role of Tmem59 in activated microglial cells during the neuroimmune response, and further lay the foundation for the elucidation of the mechanism underlying neuroinﬂammatory-related diseases. Research Support: This study was supported by the National Natural Science Foundation of China (Project No. 81571345, 81701732), the Research Center on Aging and Medicine, Fudan University (Project No: IDF151006), National Key Research and Development Program Foundation of China(No: 2016YFC1306403), National Key Research and Development Program Foundation of China(No: 2016YFC1306403), Natural Science Foundation and Major Basic Research Program of Shanghai(No: 16JC1420100), Natural Science Foundation and Major Basic Research Program of Shanghai(No: 16JC1420502)

Dcf1 Deficiency Attenuates the Role of Activated Microglia During Neuroinflammation.

Tmem59 Deletion Ac Vates Microglia And Reduces Phagocytic Capacity

Interferon Regulatory Factor 5 Regulates the Phagocytosis of Microglia and Alleviate Alzheimer's Pathology.

Interferon Regulatory Factor 5 Mediates Lipopolysaccharide-Induced Neuroinflammation

The Neuro-Inflammatory Microenvironment: an Important Regulator of Stem Cell Survival in Alzheimer’s Disease

Function of CSF1 and IL34 in Macrophage Homeostasis, Inflammation, and Cancer.

Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model

Guard of Delinquency? A Role of Microglia in Inflammatory Neurodegenerative Diseases of the CNS

CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke

Microglia nuclear receptor corepressor 1 deficiency alleviates neuroinflammation in mice

Dlg1 Knockout Inhibits Microglial Activation and Alleviates Lipopolysaccharide-Induced Depression-Like Behavior in Mice

A Neuron-Immune Circuit Regulates Neurodegeneration in the Hindbrain and Spinal Cord of Arf1-ablated Mice.

Microglial responses to peripheral type 1 interferon

Cerebral dopamine neurotrophic factor protects microglia by combining with AKT and by regulating FoxO1/mTOR signaling during neuroinflammation.

Microglial Pdcd4 deficiency mitigates neuroinflammation-associated depression via facilitating Daxx mediated PPARγ/IL-10 signaling

The Function Of Brain Th1-Like Regulatory T Cells In Suppressing Lethal Immune Pathology And Neurological Deterioration During Cryptococcus Neoformans Meningoencephalitis

An Immunomodulatory Role of Fc Receptor Γ Chain Independent of FcγR Ligation by IgG in Acute Neuroinflammation Triggered by MPTP Intoxication.

Neonatal inflammation impairs developmentally-associated microglia and promotes a highly reactive microglial subset

Zinc Finger Protein 335 Mediates Lipopolysaccharide‐induced Neurodegeneration and Memory Loss As a Transcriptional Factor in Microglia

Inflammation Negatively Regulates FOXP3 and Regulatory T-cell Function Via DBC1.

Microglial PCGF1 alleviates neuroinflammation associated depressive behavior in adolescent mice